type here...

CATEGORIES

Healthcare

LATEST

1...535455...76Page 54 of 76

TRENDING

EDITORS CHOICE

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Real-World Repercussions of Mislabeling Treatments as Vaccines

Robert Turner, Founding Editor -
Vaccinate, inoculate and immunize are three words that describe the "jab" people get to guard them against serious infectious illnesses. Harmonious - yes - but each offers a different consumer expectation.

The New Covid Vaccine Trials. Has Moderna Just Crossed an Ethical Line?

Robert Turner, Founding Editor -
Moderna has just announced the launch of a new series of Covid Vaccine trials for its mRNA vaccine. These trials are to be held on children, some as young as six months.

Reckoning or Opportunity?

Richard Hatzfeld -
How America’s pharmaceutical industry can help prevent an erosion of the U.S. healthcare system.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories